APA (7th ed.) Citation

Horak, P., Weischenfeldt, J., Amsberg, G. v., Beyer, B., Schütte, A., Uhrig, S., . . . Schlomm, T. (2019). Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance. Cold Spring Harbor molecular case studies, 5(2), . https://doi.org/10.1101/mcs.a003657

Chicago Style (17th ed.) Citation

Horak, Peter, et al. "Response to Olaparib in a PALB2 Germline Mutated Prostate Cancer and Genetic Events Associated with Resistance." Cold Spring Harbor Molecular Case Studies 5, no. 2 (2019). https://doi.org/10.1101/mcs.a003657.

MLA (9th ed.) Citation

Horak, Peter, et al. "Response to Olaparib in a PALB2 Germline Mutated Prostate Cancer and Genetic Events Associated with Resistance." Cold Spring Harbor Molecular Case Studies, vol. 5, no. 2, 2019, https://doi.org/10.1101/mcs.a003657.